Aspira Women’s Health (NASDAQ:AWH) Announces Quarterly Earnings Results

Aspira Women’s Health (NASDAQ:AWHGet Free Report) posted its earnings results on Monday. The company reported ($0.28) EPS for the quarter, beating the consensus estimate of ($0.32) by $0.04, Yahoo Finance reports. The firm had revenue of $2.42 million during the quarter, compared to the consensus estimate of $2.60 million. During the same quarter in the prior year, the business posted ($0.28) earnings per share.

Aspira Women’s Health Price Performance

Shares of AWH opened at $1.36 on Wednesday. Aspira Women’s Health has a 1 year low of $0.86 and a 1 year high of $6.75. The company has a market capitalization of $16.93 million, a price-to-earnings ratio of -0.75 and a beta of 1.54. The business has a 50-day moving average of $1.45 and a 200-day moving average of $2.81.

Wall Street Analyst Weigh In

Separately, StockNews.com upgraded Aspira Women’s Health from a “sell” rating to a “hold” rating in a research report on Wednesday.

Check Out Our Latest Stock Analysis on AWH

About Aspira Women’s Health

(Get Free Report)

Aspira Women's Health Inc, together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States. The company's products include Ova1Plus, a qualitative serum test to assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker test intended to maintain Ova1's high sensitivity; and OvaWatch, a laboratory developed tests to assist in the initial clinical assessment of malignancy risk in all women thought to have an indeterminate or benign adnexal mass.

Featured Stories

Earnings History for Aspira Women's Health (NASDAQ:AWH)

Receive News & Ratings for Aspira Women's Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspira Women's Health and related companies with MarketBeat.com's FREE daily email newsletter.